DiaMedica Therapeutics (DMAC) Other Working Capital Changes (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Other Working Capital Changes of $67500.0 for Q1 2026, down 84.0% on a YoY basis from $422000.0 in Q1 2025, and up 87.5% quarter-over-quarter from $36000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Other Working Capital Changes (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Other Working Capital Changes for 9 years, with the latest figure at $67500.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 84.0% year-over-year to $67500.0; the trailing twelve-month figure through Mar 2026 stood at $67500.0 (up 139.02% YoY), and the FY2025 full-year result was $15000.0, down 96.2% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $67500.0, up from $36000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $455000.0 in Q3 2024, with the low at -$700000.0 in Q4 2023.
- Historically, Other Working Capital Changes has averaged $52492.2 across 5 years, with a median of $46250.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 1233.33% — and 2024, when it jumped 2290.0%.
- DiaMedica Therapeutics' Other Working Capital Changes stood at -$80000.0 in 2022, then plunged by 775.0% to -$700000.0 in 2023, then surged by 92.43% to -$53000.0 in 2024, then soared by 167.92% to $36000.0 in 2025, then surged by 87.5% to $67500.0 in 2026.
- The last three Other Working Capital Changes figures came in at $67500.0 (Q1 2026), $36000.0 (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,500.00 |
| Mar 31, 2026 | 67,500.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | 455,000.00 |
| Sep 30, 2024 | 455,000.00 |
| Jun 30, 2024 | 298,750.00 |
| Jun 30, 2024 | 298,750.00 |
| Mar 31, 2024 | 158,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Dec 31, 2023 | -700,000.00 |
| Dec 31, 2023 | -700,000.00 |